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Background: Patients with cardiovascular disease (CVD) are reported to have a poorer health-related quality of
life (HRQoL) compared to healthy age- and gender-matched individuals. Moreover, HRQoL seems to predict
survival in CVD populations. We studied HRQoL and the association with outcome during follow-up in a
population undergoing surgery for peripheral artery disease or cerebrovascular large artery disease.
Methods: In the Athero-Express biobank cohort study patients ﬁlled in a questionnaire containing RAND-36. We
stratiﬁed the cohort to compare HRQoL scores (range 0–100, higher scores representing better HRQoL) and
assessed three-year event-free survival for composite cardiovascular endpoints of patients with good (above
median) versus poor (equal to and below median) HRQoL at baseline. Additionally we compared the cohort to
a healthy age-matched population.
Results: 2012 and 865 patients undergoing carotid endarterectomy (CEA) or endarterectomy of femoral/iliac
arteries (FEA) were included respectively. The median HRQoL was 75 (IQR 0–100 (both patient groups)) for
physical role limitations versus 0 (IQR 0–100 (CEA) and 0–66.7 (FEA)) for emotional role limitations. No
differences in HRQoL subscores were found, CVD burden did not associatewith HRQoL and three-year composite
event rates did not associate with the reported HRQoL in both CEA and FEA. Both groups had poor HRQoL scores
compared to an age-matched general population, especially regarding emotional role limitations and social
functioning.
Conclusions:HRQoL is poor and does not associatewith CVD burdenwithin patients suffering from severe athero-
sclerotic disease. Reported HRQoL was not associated with incident cardiovascular events during follow-up.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Background
Cardiovascular diseases (CVDs) are the world's leading cause of
death [1]. Themajority of CVDs are caused by atherosclerosis, a systemic
inﬂammatory disease that manifests in different organs including the
brain, heart, kidneys and legs. Disease burden of CVD is high as
symptomatic atherosclerosis in these organs can be physically as well
as mentally disabling. Physical functioning is for example affected by
paralysis due to cerebrovascular ischemia, while depression is known
to co-occur with cardiovascular diseases [2].31 88 7555234.
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land Ltd. This is an open access articScoring systems of health-related quality of life (HRQoL), such as
RAND-36 (a questionnaire equivalent to SF-36) are developed to mea-
sure the subjectively perceived inﬂuence of disease on physical, social
and emotional functioning [3,4]. Investigating HRQoL in various patient
groups is clinically relevant as patients with poor HRQoL might beneﬁt
from referral to both occupational therapy for simple practical interven-
tions and psychological support to learn to cope with their emotional
and physical problems.
Patients with symptomatic atherosclerosis, such as peripheral
arterial occlusive disease [5], carotid artery occlusive disease [6],
coronary artery disease [7], abdominal aortic aneurysms [8] and stroke
[9], as well as the known risk factors for atherosclerosis, e.g. hyperten-
sion [10], diabetes [11] and obesity [12], are reported to have a poorer
HRQoL as measured by SF/RAND-36 when compared to healthy age
and gender matched individuals even when they are free of symptoms
[13]. Patients with risk factors but without overt CVD report declinedle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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HRQoL. Individuals with diagnosed CVD report even lower scores on
the physical subdomains with notably declined mental HRQoL scores
as well, although social functioning remains largely unaffected.
Moreover, compromised quality of life seems to be an independent
predictor for survival in CVD populations [14–16].
The purpose of this study is to investigate whether HRQoL differs
between people with different cardiovascular disease burdens in a
cohort of patients suffering from severe atherosclerotic disease
undergoing surgery for peripheral artery disease or cerebrovascular
large artery disease. Furthermore cardiovascular event rates during
follow-up are compared between groups with differentially reported
HRQoL. Additionally we compared the cohort to a healthy age matched
population.
We hypothesize that among patients with severe atherosclerotic
disease, HRQoL varies depending on cardiovascular disease burden. A
negative effect of poor HRQoL on cardiovascular event rates during
follow-up is expected. We expect a HRQoL in the patients that is signif-
icantly worse than the general population.
2. Methods
2.1. Population
Since 2002 the Athero-Express biobank study is an ongoing cohort
study that includes carotid and femoral endarterectomy patients from
two large tertiary vascular referral hospitals in The Netherlandswithout
any exclusion criteria. Upon surgery, atherosclerotic plaques are obtain-
ed for histological assessment. To date, over 3000 carotid and femoral
endarterectomy patients have been included. In the three years of
follow-up time, in which patients are asked to ﬁll in a follow-up
questionnaire after 1, 2, and 3 years, approximately 30% of patients
reach an endpoint of cardiovascular origin. Study outline and protocol
have been described in detail before [17]. Upon inclusion in the
Athero-Express biobank study patients are asked to ﬁll in a detailed
questionnaire that contains 36 questions from RAND-36. All patients
that were included up to September 2013 and completed the
questionnaire were included in the present analysis.
2.2. Measurement of HRQoL
HRQoL was measured according to the validated Dutch version of
RAND-36. Scores on all nine subdomains (physical functioning (PF),
social functioning (SF), role limitations due to physical functioning
(RP), role limitations due to emotional functioning (RE), mental health
(MH), vitality (VT), bodily pain (BP), general health perception (GH)
and health change (HC)) were computed to a scale from 0 to 100 with
higher scores representing better HRQoL.
HRQoL measures in healthy controls were obtained from the Dutch
RAND-36 manual [3]. The manual describes a validation study in a
random sample of 1063 citizens of the Dutch municipality of Emmen
in 1992. Among others they were stratiﬁed by age.
2.3. Measurement of cardiovascular disease burden
Cardiovascular disease burden was determined in several ways.
Firstly, the symptomatology of the operated artery, e.g. indication for
surgery, was determined. Symptomatology of the treated femoral/iliac
endarterectomy patients was assessed using the Fontaine classiﬁcation.
For carotid endarterectomy patients were stratiﬁed according to
inclusion diagnosis (stroke, transient ischemic attack patients, patients
with ocular symptoms and asymptomatic patients). Secondly, the
presence of different risk factors (age, male sex, obesity, smoking,
hypertension, diabetes, hypercholesterolemia) was assessed. Thirdly,
the history of a second atherosclerotic organ concomitant to the operat-
ed artery (deﬁned by having a history of myocardial infarction, stroke,narrowing carotid artery or peripheral arterial disease) was evaluated.
All data were collected from patient ﬁles. The presence of risk factors
and history of atherosclerotic disease were binned into binary scores
(present/absent) as much as possible.2.4. Deﬁnition of endpoints
A cardiovascular composite endpoint was deﬁned as having at least
one of the following events during follow-up: (fatal) myocardial
infarction, (fatal) cerebral infarction or bleeding, coronary angioplasty
or coronary artery bypass grafting, peripheral arterial intervention,
fatal heart failure, fatal aneurysm rupture, other cardiovascular death,
leg amputation or sudden death. Endpoints were collected from
validated follow-up of the Athero-Express biobank cohort. For cardio-
vascular endpoint analyses, HRQoL scores were binned into ‘poor’
(equal to and below median) and ‘good’ (above median).2.5. Ethics
All patients provided written informed consent. The study protocol
of the Athero-Express biobank study has been approved by the local
medical ethics committees.2.6. Statistical analysis
Descriptive statistics were used to analyze the demographics of the
population. To explore response bias as a potential confounder,
univariate analysis was carried out for associations between baseline
characteristics and response rates (chi-square tests for categorical vari-
ables and t-tests for continuous variables). p-Values b0.05 were consid-
ered statistically signiﬁcant. Because of non-normal distribution of
HRQoL scores, nonparametric testswere used to compare HRQoL scores
between groupswith the absence and presence of risk factors, history of
previous (symptomatic) atherosclerotic disease and symptomatology.
Dichotomous variables were compared using the Mann–Whitney U
test, categorical variables were compared using the Kruskal–Wallis
test. After correcting for multiple testing (18 tests in each of the 9
HRQoL subdomains) using the Bonferroni correction, p-values b0.003
were considered statistically signiﬁcant. Potential confounders in the
relation between symptomatology and any of the nine HRQoL
subdomains were identiﬁed by ANOVA for continuous variables and
linear-by-linear association chi-square tests for categorical variables.
Variables with p b 0.20 were added to a multivariate regression
model. After correcting for multiple testing (nine subdomains in two
separate populations) using Bonferroni correction, p-values b0.003
were considered statistically signiﬁcant. Reference sets for the general
population were obtained from the RAND-36 manual. To compare sur-
vival of good and poor HRQoL, we plotted Kaplan–Meier curves for the
composite cardiovascular endpoint stratiﬁed to poor and good HRQoLs.
Differences between the stratawere testedwith log rank tests. SPSS ver-
sion 20was used for all analyses. The reporting of this study conforms to
the STROBE statement [18].3. Results
The current study included 2012 carotid endarterectomy (CEA)
patients and 865 patients with endarterectomy of iliac or femoral arter-
ies (FEAs). Of CEA and FEA patients 68% and 72%weremale respectively.
Agewas 69 (range 35–93) (CEA) and 68 (range 30–100) (FEA). Baseline
characteristics are shown in Table 1. Loss to follow-up rates were 10.3%
in FEA and 9.3% in CEA with median follow-up times of 2.9 years and
3.0 years respectively. In total, 834 patients reached an endpoint of
cardiovascular origin, 469 (23%) after CEA and 379 (44%) after FEA.
Table 1
Baseline characteristics.
Operating site Carotid artery n = 2012 Femoral/iliac artery n = 865
Age (mean) (SD) 68.96 (9.29) 67.64 (9.14)
Males (n) (%) 1376/2012 (68.4%) 620/865 (71.7%)
BMI (mean) (SD) 26.40 (3.93) 26.28 (8.19)
GFR (mean) (SD) 72.17 (20.70) 79.45 (48.51)
Smoking (n) (%) 672/1953 (34.4%) 340/844 (40.3%)
Hypertension (n) (%) 1438/1948 (73.8%) 623/839 (74.3%)
Diabetes (n) (%) 454/2003 (22.7%) 257/862 (29.8%)
Hypercholesterolemia (n) (%) 1240/1832 (67.7%) 526/765 (68.8%)
History of MI (n) (%) 408/1987 (20.5%) 238/853 (27.9%)
History of stroke/TIA (n) (%) 1272/1889 (67.3%) 113/835 (13.5%)
Restenosis (n) (%) 85/1972 (4.3%) 139/770 (18.1%)
Contralateral stenosis N50% (n) (%) 809/1786 (45.3%) 209/340 (61.5%)
History of intermittent claudication (n) (%) 368/622 (59.2%) History of narrowing carotid artery (n) (%) 148/844 (17.5%)
Presenting symptom CEA (n) (%) Ankle–brachial index operated leg (mean, SD) 0.59 (0.21)
*Asymptomatic 272/1998 (13.6%) Fontaine classiﬁcation for femorals (n) (%)
*Ocular 310/1998 (15.5%) *Fontaine IIb 401/736 (54.5%)
*TIA 876/1998 (43.8%) *Fontaine III 184/736 (25.0%)
*Stroke 540/1998 (27.0%) *Fontaine IV 151/736 (20.5%)
Abbreviations: SD = standard deviation, BMI = body mass index, GFR = glomerular ﬁltration rate, MI = myocardial infarction, TIA = transient ischemic attack and CEA = carotid
endarterectomy.
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The response rates for the RAND-36 were 68% (n = 1374) for CEA
and 63% (n = 548) for FEA. There were no signiﬁcant differences
between responders and non-responders on baseline characteristics in
both groups (data not shown). Event-free survival between responders
and non-responders did not differ within CEA or FEA patient groups
(data not shown).Fig. 1. Health-related quality of life scores, stratiﬁed by operating site. Carotid: carotid
endarterectomy patients, and femoral/iliac: femoral/iliac endarterectomy patients.3.2. Health-related quality of life scores
HRQoL scores did not differ between CEA and FEA patients (Fig. 1). In
both disease groups, no difference in any of the HRQoL subdomains was
observed between patients with different cardiovascular disease
burdens. Firstly, HRQoL did not differ on the basis of symptomatology
(Fig. 2a and b). Data are shown for PF and RE as PF was unexpectedlyFig. 2. Health-related quality of life scores, stratiﬁed by symptomatology. A: inclusion
diagnosis for carotid endarterectomy patients and B: Fontaine classiﬁcation for femoral/
iliac endarterectomy patients; abbreviations: asympt = asymptomatic and TIA = tran-
sient ischemic attack.
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edly low across all groups. Secondly, no difference was found between
patients with and without common risk factors such as male sex, age,
hypertension, diabetes, smoking, hypercholesterolemia or obesity
(data not shown). Secondly, no difference was found between patient
groups with and without a history of cardiovascular disease
(Supplemental Table 2). Correction for potential confounding factors
did not alter the results.
Event rates were not inﬂuenced by below median scores on any of
the subdomains of HRQoL in both CEA and FEA patient groups
(Supplemental Table 3). Data are shown in Fig. 3 for SF and RE because
these subdomains differed most from the reference population (see
Section 3.3).
3.3. Comparison with general population
Athero-Express patients (both CEA and FEA) report a poor HRQoL
compared to healthy Dutch age-matched individuals (Table 2). The
decline ranges from 5 points (MH, BP, GH, HC) to 50 points (RE) on a
scale from 0 to 100. In the general population, HRQoL declines with
age, especially in the physical subdomains. On all subdomains, both
CEA and FEA patients in the Athero-Express cohort report a lower
HRQoL than 85-year old control subjects. The subdomains that are
particularly affected are SF and RE.
4. Discussion
According to RAND-36 health-related quality of life is poor, but no
differences were observed between subgroups of a severely atheroscle-
rotic population with carotid or femoral stenosis undergoing surgery.
Furthermore, HRQoLwas not associatedwith event-free survival during
three years of follow-up in both patient groups.
One possible explanation is that all Athero-Express patients have a
severe symptomatic type of atherosclerosis, leading to an equally poorFig. 3. Three year event-free survival for good and poor HRQoL. A: carotid artery endarterecto
HRQoL above median and dotted gray line: HRQoL equal to and below median; abbreviations:HRQoL across the burden groups. Furthermore, Athero-Express patients
are all operated on and because of stringent protocols for carotid
endarterectomy (surgery within two weeks after the cerebral event)
some are only recently confronted with this life threatening disease
and the need for vascular surgery, which could lead to emotional dis-
tress. This could especially account for the poor scores on functioning
due to emotional role limitations in both Athero-Express populations,
also when compared to the general population. Depression, known to
be of high incidence in patients with CVD, seems to ﬁt this ﬁnding less
as a cause since scores on mental health were nearly unaffected
compared to the general population.
Comparison of outcomes of the HRQoL scores of the Athero-Express
biobank study remains suboptimal. Firstly, the RAND-36 HRQoL
questionnaire is being replaced by SF-36 in current literature. The
SF-36 and RAND-36 are roughly, but not totally comparable (bodily
pain and general health are calculated differently). Secondly,
researchers tend to display their outcomes in graphs that do not
contain the actual scores, making extraction of data a challenging
expedition. Thirdly, both RAND-36 and SF-36 scores are often
presented as means with standard deviations, which cannot be
interpreted correctly since the outcome of both questionnaires is
not normally distributed. In this way, information is lost and a proper
comparison is impossible.
When compared to other (SF-36) CEA patient cohorts, patients of
the Athero-Express biobank operated on carotid arteries exhibit poor
HRQoL scores on functioning to emotional role limitations, whereas
impact on role limitations due to physical functioning is relatively low.
Stolker et al. [19] for example report a 20 point lower HRQoL score in
the RP subdomain at baseline than the Athero-Express patients. This
could be explained by the selection of “high risk” CEA patients in their
SAPPHIRE study. However, Cohen et al. [20] (CREST study group) report
a 10 point lower HRQoL score on RP and a 40 point higher score on RE.
Strikingly, because both cohorts contain more asymptomatic patients
than the Athero-Express cohort (70% and 47% respectively), they aremy patients and B: femoral/iliac artery endarterectomy patients; continuous black line:
SF = social functioning and RE = role limitations due to emotional functioning.
Table 2
Comparison of HRQoL with the Dutch general population.
Dutch reference population AE carotid artery AE femoral/iliac artery
Age 55–64 Age 65–75 Age 75–85 Age 85+ Mean age: 69 Mean age: 68
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Physical functioning 72.7 (24.4) 66.7 (26) 56.0 (26.0) 60.0 (31.8) 55.7 (28.8)* 55 (35–80) 57.7 (28.6) 60 (35–85)
Social functioning 86.6 (21.4) 83.2 (23.7) 82.0 (24.9) 75.1 (31.1) 63.1 (28.6)* 62 (50–87.5) 66 (28.4)* 62.5 (50–87.5)
Role limitations, physical 76.5 (38.1) 69.1 (42.5) 60.1 (43.1) 76.6 (35.9) 56 (44) 75 (0–100) 54.6 (44.2)* 75 (0–100)
Role limitations, emotional 90.1 (24.5) 82.9 (33.8) 73.7 (40.4) 82.4 (39.3) 33.2 (43.1)* 0 (0–100) 32.6 (43)* 0 (0–66.7)
Mental health 77.1 (18.7) 75.9 (17.3) 76.9 (14.3) 78.3 (15.7) 70 (20.3) 72 (56–84) 70.9 (19) 72 (60–84)
Vitality 67.0 (21.3) 64.2 (22.0) 60.1 (21.3) 67.5 (23.2) 54.6 (22.4)* 55 (40–70) 56.5 (20.7)* 60 (40–70)
Pain 74.7 (25.0) 74.8 (28.0) 72.0 (30.3) 77.3 (26.7) 68.5 (28.7) 69.4 (44.9–100) 69.5 (28) 68.4 (44.9–100)
General health perception 64.4 (22.2) 60.1 (23.9) 59.0 (21.2) 61.4 (21.3) 54.6 (20.1) 55 (40–70) 55.8 (19.5) 55 (40–70)
Health change 48.7 (15.4) 46.8 (20.5) 45.1 (18.7) 50.0 (0.0) 40.1 (27.0) 50 (25–50) 41.8 (25.1) 50 (25–50)
Abbreviations: SD = standard deviation, IQR = interquartile range and * = p b 0.001 compared to age matched group.
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lower. Two different European studies exhibit the same pattern. A Brit-
ish study [21] with 13% asymptomatic patients (equal to the Athero-
Express cohort) reports RE that is 30 points higher than Athero-
Express patients while RP is 20 points lower. The Serbian cohort of
Vlajinac et al. [22] with 35% stroke patients reported an excellent PF
(71.7) at baseline but the same pattern exists within the role limitation
subdomains: lower PF and higher RE than Athero-Express patients
(−15 and +15 points respectively). All cohorts, including the Athero-
Express cohort, have a mean age of around 70.
Mazari et al. [23] recorded SF-36 scores in 178 patients that were
about to undergo femoropopliteal angioplasty (median age 70) and
Van Hattum et al. [24] report HRQoL scores of 1001 patients (mean
age 62) before peripheral bypass surgery. Compared to these cohorts,
Athero-Express FEA patients differ in the same way as Athero-Express
CEA patients do: a poor score on RE with relatively high RP. There is
no clear explanation for the differences found in functioning due to
role limitations.
A possible limitation of the Athero-Express biobank study regarding
HRQoL is the fact that the Athero-Express population only consists of
patients that have undergone surgery, leading to selection bias of
patients that are physically able to handle the procedure. Even more
severely disabled patients are thus excluded, leading to a possible over-
estimation of the actual HRQoL. However, as inclusion of non-operable
patients would further lower the scores, this would probably not affect
the already observed ‘ﬂoor effect’.
Non-response on the RAND-36 is not thought to inﬂuence the
outcome either, because response rates did not differ with cardiovascular
disease burden. Only patients with a second affected peripheral artery
had consistently lower response rates in CEA and FEA, but this differ-
ence did not reach signiﬁcance. This could however implicate that
more severely disabled patients may not have ﬁlled in the question-
naire. Since survival rates did not differ between responders and non-
responders in both CEA and FEA patients, impact on survival is not to
be expected.
Another possible confounder is socio-economic status, for it is
known that patients with a low socio-economic status experience a
signiﬁcantly lower health-related quality of life compared to patients
with a high socio-economic status [25]. This difference could well be
explained by education. Both factors are not measured in the Athero-
Express biobank, so they could not be corrected for and may have
introduced confounding.
Atherosclerotic disease affecting the cerebrovascular and peripheral
arteries has a large impact on HRQoL, independent of risk factors or
medical history. Considering the systemic nature of the disease and
the lack of options to completely abolish atherosclerotic plaque burden
in individual patients, treatment should include the improvement of
HRQoL. Health care specialists that work with patient groups affected
by atherosclerosis therefore need to be aware of the poor quality of
life of their patients to be able to offer practical physical and emotionalsupport or detect more severe mental health issues that need attention
from psychological experts.
5. Conclusion
Using RAND-36, HRQoL is poor, especially regarding emotional and
social functioning, but cardiovascular disease burden does not inﬂuence
HRQoL within patients suffering from severe atherosclerotic disease
undergoing surgery. In addition, reported quality of life was not
associated with incident cardiovascular events during follow-up.
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